H.I.G. Capital Invests in Outcomes

H.I.G. Capital, a prominent global alternative investment firm, has successfully acquired Outcomes One, a leading provider of clinical network services and pharmacy technology. The deal, announced on September 2, 2026, involves an undisclosed transaction value. Headquartered in Orlando, Florida, Outcomes One operates a national network that encompasses approximately 85% of U.S. pharmacies, enhancing patient health through pharmacist-led clinical interventions and medication-based care.

Outcomes One specializes in delivering integrated technology solutions that streamline pharmacy operations and improve patient outcomes. The company offers a comprehensive suite of services, including pharmacy management software, workflow automation tools, and clinical intervention platforms. In 2025 alone, Outcomes facilitated over 10 million clinical interventions, impacting 130 million covered lives. This extensive reach positions Outcomes as a critical player in the healthcare landscape, supporting pharmacies, health plans, and pharmaceutical manufacturers with innovative technology and services.

The strategic rationale behind H.I.G. Capital's acquisition lies in the growing importance of pharmacist-led care in the healthcare ecosystem. As the industry shifts towards more integrated and patient-centric models, Outcomes' capabilities in enhancing medication adherence and improving health outcomes are increasingly vital. H.I.G. aims to leverage its resources and expertise to further develop Outcomes' technology platforms, such as Rx30 and Computer-Rx, which are essential for modern pharmacy operations.

The broader market implications of this acquisition reflect ongoing trends in the healthcare and pharmacy sectors. As demand for efficient and effective healthcare solutions rises, partnerships like this one are likely to drive innovation and improve service delivery. The integration of advanced technology in pharmacy operations not only enhances patient care but also creates new economic opportunities for pharmacy partners. H.I.G.'s investment in Outcomes One underscores a commitment to advancing the role of pharmacies within the healthcare system, positioning both firms for growth in an evolving market landscape.

Overall, this acquisition signals a significant move towards enhancing the capabilities of pharmacies and improving patient health outcomes, aligning with broader trends of technological integration and value-based care in the healthcare industry.